Form 4: Quaker Chemical Grants SVP, CTO 913 Restricted Stock Units

Quaker Chemical Corp. granted 913 restricted stock units to SVP and CTO Christine Procopio Johnson, vesting in three annual installments starting March 15, 2026.

Summary

• Christine Procopio Johnson, SVP and CTO of Quaker Chemical Corp. (KWR), was granted 913 Restricted Stock Units (RSUs).
• The transaction date for this grant was October 15, 2025.
• These RSUs were granted under the Company's Long-Term Performance Incentive Plan.
• Each restricted stock unit represents a contingent right to receive one share of KWR common stock.
• The RSUs will vest in three annual installments, with the first vesting date on March 15, 2026.
• Dividend equivalent rights will accrue on these restricted stock units when dividends are paid on KWR's common stock.
• Following this transaction, Christine Procopio Johnson beneficially owns 913 derivative securities (RSUs) directly.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. This is a routine executive compensation event that aligns management's interests with shareholders, which is generally viewed favorably. It does not indicate any immediate operational or financial changes, but rather a standard governance practice.

Positives

• The grant of restricted stock units aligns the executive's long-term interests with those of shareholders, promoting retention and performance.
• The inclusion of dividend equivalent rights ensures the executive benefits from shareholder returns even before vesting.

Risks

• The value of the restricted stock units is contingent on the future market price of KWR common stock, exposing the executive to market fluctuations.
• Failure to meet vesting conditions (e.g., continued employment) would result in forfeiture of the unvested units.

Future Outlook

The grant of restricted stock units with a multi-year vesting schedule indicates a commitment to retaining key executive talent and aligning their incentives with the company's long-term performance.

Industry Context

The grant of restricted stock units is a common and standard practice in executive compensation across various industries, including specialty chemicals, to attract, retain, and motivate senior leadership by aligning their financial interests with shareholder value creation.

Comparison to Industry Standards

• The use of time-based restricted stock units as a component of executive compensation is a widely adopted practice across publicly traded companies, consistent with industry standards for long-term incentive plans.
• While the specific number of units granted is tailored to the executive's role and the company's compensation philosophy, the filing does not provide specific benchmarks or comparable company data to assess the grant size relative to industry peers.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant aligns the interests of a key executive with shareholders, potentially fostering long-term value creation.
• Employees: This reflects the company's ongoing executive compensation strategy, which can influence broader employee incentive programs.

Next Steps

• The restricted stock units will vest in three annual installments, beginning on March 15, 2026.
• Upon vesting, the restricted stock units will convert into shares of KWR common stock.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of restricted stock units to a senior executive as part of their compensation package. Such grants are standard practice and do not typically provide new material information that would warrant a change in investment recommendation. The transaction aligns executive interests with shareholders but does not signal a fundamental shift in the company's outlook or performance.

Keywords

KWR, Quaker Chemical, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Form 4, Equity Grant